| Item Type | Name |
|
Concept
|
Prognosis
|
|
Academic Article
|
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
|
|
Academic Article
|
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission.
|
|
Academic Article
|
BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
|
|
Academic Article
|
STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
|
|
Academic Article
|
Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis.
|
|
Academic Article
|
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
|
|
Academic Article
|
Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
|
|
Academic Article
|
Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
|
|
Academic Article
|
Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
|
|
Academic Article
|
The prognostic value of CXCR4 in acute myeloid leukemia.
|
|
Academic Article
|
Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
|
|
Academic Article
|
Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia.
|
|
Academic Article
|
Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia.
|
|
Academic Article
|
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study.
|
|
Academic Article
|
The diagnostic and clinical impact of genetics and epigenetics in acute myeloid leukemia.
|
|
Academic Article
|
Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis.
|
|
Academic Article
|
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
|
|
Academic Article
|
''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.
|
|
Academic Article
|
Acute myeloid leukemia.
|
|
Academic Article
|
Biological characterization of stage I follicular lymphoma according to extranodal or nodal primary origin and t(14;18) status using high-resolution array-based comparative genomic hybridization.
|
|
Academic Article
|
Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.
|
|
Academic Article
|
Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
|
|
Academic Article
|
Hepatosplenic gamma delta T-cell lymphoma--not just alphabet soup.
|
|
Academic Article
|
Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.
|
|
Academic Article
|
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.
|
|
Academic Article
|
A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
|
|
Academic Article
|
Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis.
|
|
Academic Article
|
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
|
|
Academic Article
|
Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia.
|
|
Academic Article
|
How I investigate chronic myelomonocytic leukemia.
|
|
Academic Article
|
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC).
|
|
Academic Article
|
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
|
|
Academic Article
|
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype.
|
|
Academic Article
|
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group.
|
|
Academic Article
|
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study.
|
|
Academic Article
|
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.
|
|
Academic Article
|
Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.
|
|
Academic Article
|
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).
|
|
Academic Article
|
Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
|
|
Academic Article
|
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.
|
|
Academic Article
|
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.
|